Banville Law reports on a lawsuit that has been filed against AbbVie. Inc and Abbott Laboratories, Inc., which alleges that their popular Testosterone Replacement Therapy (TRT) drug, called AndroGel, proximately caused the plaintiff to suffer certain damages including a heart attack.
The complaint is one many lawsuits which have now been filed against these drug companies and which have been consolidated in a Multidistrict Litigation (MDL) taking place in US District Court for the Northern District of Illinois.
Filed under case number 1:14-cv-00776, this complaint was brought by on behalf of a man who had been prescribed AndroGel for the treatment of symptoms that he had attributed to low testosterone after having seen the defendants' advertisements for AndroGel.
According to the case, the plaintiff had taken AndroGel as prescribed and alleges that the use of AndroGel caused him to suffer a heart attack, as well as other physical and emotional damages.
Additionally, the lawsuit notes that the plaintiff did not have any prior history of the cardiac events that were allegedly caused by AndroGel.
As a result, the plaintiff seeks compensation for certain economic and noneconomic damages that resulted from his use of AndroGel.
Among other allegations, the lawsuit brings charges against AbbVie Inc. and Abbott Laboratories, Inc. for their failure to warn the public about significant risks which the companies had known about or should have known about.
Additionally, this particular case alleges that the defendants had misrepresented AndroGel with regard to the drug’s safety and effectiveness, with the intention of increasing prescriptions of the drug.
Testosterone Lawyers: Fighting For Justice In The Low T Litigation
“There are now more than 2,000 lawsuits filed in the testosterone MDL and many more are expected to join over the next few months,” said Laurence Banville, Esq.
“We are currently representing people who have suffered serious injury after being prescribed a testosterone supplement, as well as the family members of individuals who may have been harmed by these drugs.”
Banville is a sponsor of LowTestosteroneCase.com, which provides helpful information about the pending testosterone litigation, as well as access to legal representation for those who wish to file a complaint.
Please contact Laurence Banville Esq. at 888-478-9711 for all questions regarding this press release and the pending testosterone litigation.
Banville Law is a New York law firm dedicated to assisting plaintiffs in lawsuits involving personal injury, product liability and related legal matters.
165 West End Avenue, #1H
New York, NY 10023
United States (US)
April 29, 2016 – Risperdal Lawsuit Allegations Draw Concern Over Possible Gynecomastia Side Effect
April 29, 2016 – Mother Files Risperdal Lawsuit Claiming Drug Caused Development Of Son’s Gynecomastia
April 29, 2016 – Risperdal Plaintiff Awarded $1.75 Million In Damages
April 28, 2016 – Risperdal Lawsuit Plaintiffs Are Awarded $8 Million After The Death Of A Family Member
April 28, 2016 – Millions Awarded To Plaintiffs In Risperdal Lawsuit Verdicts
April 28, 2016 – Risperdal Lawsuit Trial Draws Attention To Controversial Testimony And Potentially Hidden Study Results
April 27, 2016 – Risperdal Lawsuit Plaintiffs Observe As Millions Paid Out For Risperdal Jury Verdicts
April 27, 2016 – Louisiana Risperdal Lawsuit Plaintiff Claims Drug Caused Son’s Gynecomastia Development
April 27, 2016 – U.S. Supreme Court Shows Favor To Risperdal Lawsuit Plaintiffs
April 26, 2016 – Johnson & Johnson Subsidiary Janssen Pharmaceuticals Loses Third Risperdal Lawsuit
